Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2021-03-08Chongqing's Western Science City sets new policies on talents, innovation, industry and finance
2021-03-05Mercurity Fintech Holding Inc. Announced Changes to Board Composition
2021-03-05IMAX China Reports Full-Year 2020 Financial Results
2021-03-04Pingtan Marine Enterprise Ltd. Announces $4,750,000 Registered Direct Offering of Ordinary Shares and Warrants
2021-03-04ReTo Eco-Solutions Boosts Revenue Momentum with New RMB 10.71 Million Sales Contract
2021-03-03Biotheus Announces the Closing of a New Round of Financing co-led by General Atlantic and IDG Capital
2021-03-03SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange
2021-03-03FinVolution Group to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Thursday, March 11, 2021
2021-03-02Zepp Health Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 15, 2021
2021-03-02Cango Inc. Announces Up to US$50 Million Share Repurchase Program
2021-03-01Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
2021-03-01Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited
2021-02-26AmCham South China: 94% of US Companies Optimistic towards 2021 Business Outlook in China
2021-02-26Harbour BioMed Announces NMPA Approval of IND for Combination Therapy of Next Gen Anti-CTLA-4 Antibody for Treatment of NSCLC and Solid Tumors
2021-02-25Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021
2021-02-25IT Tech Packaging, Inc. Announces Proposed Public Offering of Common Stock and Warrants
2021-02-24WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
2021-02-24Fudan MBA Program Ranks 32nd in FT Global Ranking
2021-02-23The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma
2021-02-23Wins Finance Holdings Inc. Announces Nasdaq Hearing Review Decision to Delist its Securities

First　Previous　124 125 126 127 128　Next　Last　Total 4787 20/Page Page 125 of 240 Go To: